Green Cross Corporation (006280.KS)
KRW 168000.0
(-1.7%)
KRW 168000.0
(-1.7%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 516.24 Billion KRW | 16.69% |
| 2022 | 442.4 Billion KRW | -2.76% |
| 2021 | 454.97 Billion KRW | 4.1% |
| 2020 | 437.07 Billion KRW | 7.51% |
| 2019 | 406.55 Billion KRW | 5.07% |
| 2018 | 386.92 Billion KRW | 1.48% |
| 2017 | 381.26 Billion KRW | 18.87% |
| 2016 | 320.75 Billion KRW | -1.23% |
| 2015 | 324.73 Billion KRW | 8.83% |
| 2014 | 298.39 Billion KRW | 19.35% |
| 2013 | 250.01 Billion KRW | 18.64% |
| 2012 | 210.72 Billion KRW | 6.37% |
| 2011 | 198.1 Billion KRW | 4.31% |
| 2010 | 189.91 Billion KRW | -10.28% |
| 2009 | 211.68 Billion KRW | 88.22% |
| 2008 | 112.46 Billion KRW | 36.43% |
| 2007 | 82.43 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 625.89 Billion KRW | 5.92% |
| 2024 Q1 | 590.93 Billion KRW | 14.47% |
| 2023 Q2 | 508.33 Billion KRW | 5.44% |
| 2023 Q4 | 516.24 Billion KRW | 0.15% |
| 2023 Q3 | 515.45 Billion KRW | 1.4% |
| 2023 FY | 516.24 Billion KRW | 16.69% |
| 2023 Q1 | 482.09 Billion KRW | 8.97% |
| 2022 FY | 505.08 Billion KRW | -2.76% |
| 2022 Q4 | 442.4 Billion KRW | 0.62% |
| 2022 Q3 | 439.68 Billion KRW | 0.0% |
| 2022 Q2 | 439.68 Billion KRW | -1.84% |
| 2022 Q1 | 447.9 Billion KRW | -1.55% |
| 2021 Q2 | 478.04 Billion KRW | -3.32% |
| 2021 Q1 | 494.46 Billion KRW | 13.13% |
| 2021 Q4 | 454.97 Billion KRW | -0.84% |
| 2021 FY | 506.99 Billion KRW | 4.1% |
| 2021 Q3 | 458.84 Billion KRW | -4.02% |
| 2020 Q4 | 437.07 Billion KRW | -5.26% |
| 2020 FY | 489.14 Billion KRW | 7.51% |
| 2020 Q1 | 440.2 Billion KRW | 8.28% |
| 2020 Q2 | 472.22 Billion KRW | 7.27% |
| 2020 Q3 | 461.31 Billion KRW | -2.31% |
| 2019 Q4 | 406.55 Billion KRW | 0.91% |
| 2019 Q3 | 402.88 Billion KRW | 0.56% |
| 2019 Q1 | 414.78 Billion KRW | 7.2% |
| 2019 Q2 | 400.63 Billion KRW | -3.41% |
| 2019 FY | 453.77 Billion KRW | 5.07% |
| 2018 Q4 | 386.92 Billion KRW | -4.19% |
| 2018 Q3 | 403.86 Billion KRW | -3.28% |
| 2018 FY | 431.5 Billion KRW | 1.48% |
| 2018 Q1 | 411.51 Billion KRW | 7.93% |
| 2018 Q2 | 417.55 Billion KRW | 1.47% |
| 2017 Q4 | 381.26 Billion KRW | 2.78% |
| 2017 Q3 | 370.94 Billion KRW | 4.83% |
| 2017 FY | 496.47 Billion KRW | 18.87% |
| 2017 Q1 | 337.94 Billion KRW | 5.36% |
| 2017 Q2 | 353.85 Billion KRW | 4.71% |
| 2016 Q3 | 345.21 Billion KRW | -1.92% |
| 2016 FY | 487.81 Billion KRW | -1.23% |
| 2016 Q4 | 320.75 Billion KRW | -7.09% |
| 2016 Q1 | 344.16 Billion KRW | 5.99% |
| 2016 Q2 | 351.96 Billion KRW | 2.27% |
| 2015 Q1 | 307.13 Billion KRW | 2.93% |
| 2015 Q3 | 304.48 Billion KRW | -4.27% |
| 2015 Q4 | 324.73 Billion KRW | 6.65% |
| 2015 Q2 | 318.07 Billion KRW | 3.56% |
| 2015 FY | 523.63 Billion KRW | 8.83% |
| 2014 Q4 | 298.39 Billion KRW | 7.7% |
| 2014 Q3 | 277.07 Billion KRW | 1.8% |
| 2014 FY | 428.14 Billion KRW | 19.35% |
| 2014 Q1 | 256.31 Billion KRW | 2.52% |
| 2014 Q2 | 272.18 Billion KRW | 6.19% |
| 2013 Q3 | 238.85 Billion KRW | -3.01% |
| 2013 FY | 279.21 Billion KRW | 18.64% |
| 2013 Q1 | 226.2 Billion KRW | 7.35% |
| 2013 Q2 | 246.25 Billion KRW | 8.86% |
| 2013 Q4 | 250.01 Billion KRW | 4.67% |
| 2012 Q2 | 221.61 Billion KRW | 4.0% |
| 2012 Q1 | 213.07 Billion KRW | 7.56% |
| 2012 FY | 222.64 Billion KRW | 6.37% |
| 2012 Q4 | 210.72 Billion KRW | -3.59% |
| 2012 Q3 | 218.57 Billion KRW | -1.37% |
| 2011 FY | 209.57 Billion KRW | 4.31% |
| 2011 Q4 | 198.1 Billion KRW | 5.4% |
| 2011 Q3 | 187.96 Billion KRW | -4.64% |
| 2011 Q2 | 197.11 Billion KRW | 1.45% |
| 2011 Q1 | 194.3 Billion KRW | 0.0% |
| 2010 Q1 | 185.28 Billion KRW | -12.47% |
| 2010 Q3 | 185.46 Billion KRW | -5.32% |
| 2010 FY | 202.03 Billion KRW | -10.28% |
| 2010 Q2 | 195.88 Billion KRW | 5.72% |
| 2009 Q1 | 130.28 Billion KRW | 15.85% |
| 2009 Q3 | 156.73 Billion KRW | 9.84% |
| 2009 Q2 | 142.69 Billion KRW | 9.52% |
| 2009 Q4 | 211.68 Billion KRW | 35.06% |
| 2009 FY | 224.89 Billion KRW | 88.22% |
| 2008 Q1 | 83.95 Billion KRW | 1.84% |
| 2008 Q4 | 112.46 Billion KRW | 9.18% |
| 2008 Q3 | 103.01 Billion KRW | 6.87% |
| 2008 Q2 | 96.39 Billion KRW | 14.81% |
| 2008 FY | 128.09 Billion KRW | 36.43% |
| 2007 FY | 93.34 Billion KRW | 0.0% |
| 2007 Q4 | 82.43 Billion KRW | 1.05% |
| 2007 Q1 | 70.05 Billion KRW | 0.0% |
| 2007 Q2 | 77.08 Billion KRW | 10.04% |
| 2007 Q3 | 81.57 Billion KRW | 5.82% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ORIENT BIO Inc. | 3.65 Billion KRW | -14026.64% |
| Green Cross Holdings Corporation | 579.72 Billion KRW | 10.95% |
| Green Cross Holdings Corporation | 516.24 Billion KRW | 0.0% |
| Pharmicell Co., Ltd. | 20.87 Billion KRW | -2373.342% |
| GeneOne Life Science, Inc. | 14.89 Billion KRW | -3365.444% |
| Celltrion, Inc. | 3041.45 Billion KRW | 83.026% |
| Samsung Biologics Co.,Ltd. | 2641.36 Billion KRW | 80.455% |
| SK bioscience Co.,Ltd. | 80.64 Billion KRW | -540.111% |
| SK Biopharmaceuticals Co., Ltd. | 102.52 Billion KRW | -403.529% |
| Prestige BioPharma Limited | 18.1 Billion KRW | -2751.712% |